An Isogenic Hemoglobin Receptor–Deficient Mutant of<i>Haemophilus ducreyi</i>Is Attenuated in the Human Model of Experimental Infection

Jaffar A. Al‐Tawfiq, Kate R. Fortney, Barry P. Katz, Antoinette F. Hood, Christopher A. Elkins, Stanley M. Spinola

The Journal of Infectious Diseases · 2000 · 90 citations · 33 references

DOIFull text

Open access

Concepts

Abstract

Haemophilus ducreyi expresses a conserved hemoglobin-binding outer-membrane protein (HgbA). To test the role of HgbA in pathogenesis, we infected 9 adults with isolate 35000 and its isogenic hgbA-inactivated mutant (FX504) on their upper arms in a double-blinded, escalating dose-response study. Papules developed at similar rates at sites inoculated with the mutant or parent. The pustule-formation rate was 55% (95% confidence interval [CI], 30. 8%-78.5%) at parent sites and 0 (95% CI, 0-10.5%) at mutant sites (P<.0001). The recovery rate of H. ducreyi from surface cultures was 16% (n=142) from parent sites and 0 (n=213) from mutant sites (P<. 0001). H. ducreyi was recovered at biopsy from 6 of 7 parent sites and from 0 of 3 mutant sites. The results indicate that hemoglobin may be a critical source of heme or iron for the establishment of H. ducreyi infection in humans.

References

33